Citi Pharma Dividend
Dividend criteria checks 2/6
Citi Pharma is a dividend paying company with a current yield of 9.71% that is well covered by earnings.
Key information
9.7%
Dividend yield
87%
Payout ratio
Industry average yield | 4.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | PK₨2.88 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: CPHL has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: CPHL's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
Citi Pharma Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (CPHL) | 9.7% |
Market Bottom 25% (PK) | 4.0% |
Market Top 25% (PK) | 13.0% |
Industry Average (Pharmaceuticals) | 4.4% |
Analyst forecast in 3 Years (CPHL) | n/a |
Notable Dividend: CPHL's dividend (9.71%) is higher than the bottom 25% of dividend payers in the PK market (3.99%).
High Dividend: CPHL's dividend (9.71%) is low compared to the top 25% of dividend payers in the PK market (12.97%).
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (86.8%), CPHL's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Insufficient data to calculate CPHL's cash payout ratio to determine if its dividend payments are covered by cash flows.